BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22213637)

  • 1. Functional protease profiling for diagnosis of malignant disease.
    Findeisen P; Neumaier M
    Proteomics Clin Appl; 2012 Jan; 6(1-2):60-78. PubMed ID: 22213637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate optimization and clinical validation of reporter peptides for MS-based protease profiling in serum specimens: a new approach for diagnosis of malignant disease.
    Yepes D; Jacob A; Dauber M; Costina V; Hofheinz R; Neumaier M; Findeisen P
    Int J Oncol; 2011 Jul; 39(1):145-54. PubMed ID: 21503574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spiking of serum specimens with exogenous reporter peptides for mass spectrometry based protease profiling as diagnostic tool.
    Findeisen P; Peccerella T; Post S; Wenz F; Neumaier M
    Rapid Commun Mass Spectrom; 2008 Apr; 22(8):1223-9. PubMed ID: 18348224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic profiling of proteases: tools for granzyme degradomics.
    van Domselaar R; de Poot SA; Bovenschen N
    Expert Rev Proteomics; 2010 Jun; 7(3):347-59. PubMed ID: 20536307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic discovery of protease substrates.
    Schilling O; Overall CM
    Curr Opin Chem Biol; 2007 Feb; 11(1):36-45. PubMed ID: 17194619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic techniques and activity-based probes for the system-wide study of proteolysis.
    auf dem Keller U; Schilling O
    Biochimie; 2010 Nov; 92(11):1705-14. PubMed ID: 20493233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N- and C-terminal degradomics: new approaches to reveal biological roles for plant proteases from substrate identification.
    Huesgen PF; Overall CM
    Physiol Plant; 2012 May; 145(1):5-17. PubMed ID: 22023699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
    Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery.
    Koomen JM; Li D; Xiao LC; Liu TC; Coombes KR; Abbruzzese J; Kobayashi R
    J Proteome Res; 2005; 4(3):972-81. PubMed ID: 15952745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease proteomics: revealing protease in vivo functions using systems biology approaches.
    Doucet A; Overall CM
    Mol Aspects Med; 2008 Oct; 29(5):339-58. PubMed ID: 18571712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical proteomics and mass spectrometry profiling for cancer detection.
    Solassol J; Jacot W; Lhermitte L; Boulle N; Maudelonde T; Mangé A
    Expert Rev Proteomics; 2006 Jun; 3(3):311-20. PubMed ID: 16771703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein profiling for cancer biomarker discovery using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and infrared imaging: a review.
    Bakry R; Rainer M; Huck CW; Bonn GK
    Anal Chim Acta; 2011 Mar; 690(1):26-34. PubMed ID: 21414433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and identification of proteases secreted by Aspergillus fumigatus using free flow electrophoresis and MS.
    Neustadt M; Costina V; Kupfahl C; Buchheidt D; Eckerskorn C; Neumaier M; Findeisen P
    Electrophoresis; 2009 Jun; 30(12):2142-50. PubMed ID: 19582717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors.
    Overall CM; Tam EM; Kappelhoff R; Connor A; Ewart T; Morrison CJ; Puente X; López-Otín C; Seth A
    Biol Chem; 2004 Jun; 385(6):493-504. PubMed ID: 15255181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical proteomics: towards early detection of cancers].
    Solassol J; Boulle N; Maudelonde T; Mangé A
    Med Sci (Paris); 2005; 21(8-9):722-9. PubMed ID: 16115457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis.
    Ménard C; Johann D; Lowenthal M; Muanza T; Sproull M; Ross S; Gulley J; Petricoin E; Coleman CN; Whiteley G; Liotta L; Camphausen K
    Cancer Res; 2006 Feb; 66(3):1844-50. PubMed ID: 16452246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel approach using MALDI-TOF/TOF mass spectrometry and prestructured sample supports (AnchorChip Technology) for proteomic profiling and protein identification.
    Leung SM; Pitts RL
    Methods Mol Biol; 2008; 441():57-70. PubMed ID: 18370311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantify this! Report on a round table discussion on quantitative mass spectrometry in proteomics.
    Quadroni M; Ducret A; Stöcklin R
    Proteomics; 2004 Aug; 4(8):2211-5. PubMed ID: 15274113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disentanglement of protease substrate repertoires.
    Van Damme P; Vandekerckhove J; Gevaert K
    Biol Chem; 2008 Apr; 389(4):371-81. PubMed ID: 18208357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.